Cargando…
Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
BACKGROUND: Cardiovascular complications are common in kidney transplant patients and calcification propensity of blood, measured as T(50), is associated with cardiovascular outcomes. Paricalcitol supplementation affects calcium/phosphate homeostasis and may affect calcification propensity. To asses...
Autores principales: | Ussif, Amin, Pihlstrøm, Hege, Pasch, Andreas, Holdaas, Hallvard, Hartmann, Anders, Smerud, Knut, Åsberg, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106758/ https://www.ncbi.nlm.nih.gov/pubmed/30134956 http://dx.doi.org/10.1186/s12882-018-1000-8 |
Ejemplares similares
-
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
por: Pihlstrøm, Hege Kampen, et al.
Publicado: (2020) -
Use of Statins in Kidney Transplant Recipients in Norway
por: Rønning, Marit, et al.
Publicado: (2022) -
Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
por: Ussif, Amin M., et al.
Publicado: (2019) -
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
por: Loftheim, Håvard, et al.
Publicado: (2012) -
Increased risk of ischaemic heart disease after kidney donation
por: Haugen, Anders J, et al.
Publicado: (2021)